Sumithra J. Mandrekar, PhD


Dr Mandrekar’s primary research interest is in the design and analysis of phase 1, phase 2, and phase 3 clinical trials in cancer. Areas of active research include adaptive dose-finding trial design, designs for biomarker validation, meta-analyses, and general statistical inference.